Kymera Therapeutics

KYMR • NASDAQ • Stock Fundamentals

Kymera Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nello Mainolfi, with a market cap of $6.7B.

Market Cap$6.7B

Employees186.0

CEONello Mainolfi

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsApr 30, 2026 · 1 month 13 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Kymera Therapeutics

Kymera Therapeutics (KYMR) has a market capitalization of $6.7B and trades on NASDAQ.

Kymera Therapeutics has approximately 186 employees.